دورية أكاديمية
أعرض في EDS

Development of molecular tools for diagnosis of Alzheimer's disease that are based on detection of amyloidogenic proteins.

التفاصيل البيبلوغرافية
العنوان: Development of molecular tools for diagnosis of Alzheimer's disease that are based on detection of amyloidogenic proteins.
المؤلفون: Kulichikhin KY; Laboratory of Amyloid Biology, St. Petersburg State University, St. Petersburg, Russia., Fedotov SA; Laboratory of Amyloid Biology, St. Petersburg State University, St. Petersburg, Russia.; I.P. Pavlov Institute of Physiology, Russian Academy of Sciences, St. Petersburg, Russia., Rubel MS; SCAMT Institute, ITMO University, St. Petersburg, Russia., Zalutskaya NM; V.M. Bekhterev National Research Medical Center for Psychiatry and Neurology, St. Petersburg, Russia., Zobnina AE; Laboratory of Amyloid Biology, St. Petersburg State University, St. Petersburg, Russia.; Sirius University of Science and Technology, Sochi, Russia., Malikova OA; Laboratory of Amyloid Biology, St. Petersburg State University, St. Petersburg, Russia.; Sirius University of Science and Technology, Sochi, Russia., Neznanov NG; V.M. Bekhterev National Research Medical Center for Psychiatry and Neurology, St. Petersburg, Russia., Chernoff YO; Laboratory of Amyloid Biology, St. Petersburg State University, St. Petersburg, Russia.; School of Biological Sciences, Georgia Institute of Technology, Atlanta, GA, USA., Rubel AA; Laboratory of Amyloid Biology, St. Petersburg State University, St. Petersburg, Russia.; Sirius University of Science and Technology, Sochi, Russia.; Department of Genetics and Biotechnology, St. Petersburg State University, St. Petersburg, Russia.
المصدر: Prion [Prion] 2021 Dec; Vol. 15 (1), pp. 56-69.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Review
اللغة: English
بيانات الدورية: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101472305 Publication Model: Print Cited Medium: Internet ISSN: 1933-690X (Electronic) Linking ISSN: 19336896 NLM ISO Abbreviation: Prion Subsets: MEDLINE
أسماء مطبوعة: Publication: 2015- : Philadelphia, PA : Taylor & Francis
Original Publication: Austin, Tex. : Landes Bioscience, 2007-
مواضيع طبية MeSH: Alzheimer Disease*/diagnosis, Aged ; Amyloid Precursor Protein Secretases ; Amyloid beta-Peptides ; Amyloidogenic Proteins ; Aspartic Acid Endopeptidases ; Biomarkers ; Humans ; Positron-Emission Tomography ; tau Proteins
مستخلص: Alzheimer's disease (AD) is the most common form of dementia that usually occurs among older people. AD results from neuronal degeneration that leads to the cognitive impairment and death. AD is incurable, typically develops over the course of many years and is accompanied by a loss of functional autonomy, making a patient completely dependent on family members and/or healthcare workers. Critical features of AD are pathological polymerization of Aβ peptide and microtubule-associated protein tau, accompanied by alterations of their conformations and resulting in accumulation of cross-β fibrils (amyloids) in human brains. AD apparently progresses asymptomatically for years or even decades before the appearance of symptoms. Therefore, development of the early AD diagnosis at a pre-symptomatic stage is essential for potential therapies. This review is focused on current and potential molecular tools (including non-invasive methods) that are based on detection of amyloidogenic proteins and can be applicable to early diagnosis of AD. Abbreviations : Aβ - amyloid-β peptide; AβO - amyloid-β oligomers; AD - Alzheimer's disease; ADRDA - Alzheimer's Disease and Related Disorders Association; APH1 - anterior pharynx defective 1; APP - amyloid precursor protein; BACE1 - β-site APP-cleaving enzyme 1; BBB - brain blood barrier; CJD - Creutzfeldt-Jakob disease; CRM - certified reference material; CSF - cerebrospinal fluid; ELISA - enzyme-linked immunosorbent assay; FGD - 18 F-fluorodesoxyglucose (2-deoxy-2-[ 18 F]fluoro-D-glucose); IP-MS - immunoprecipitation-mass spectrometry assay; MCI - mild cognitive impairment; MDS - multimer detection system; MRI - magnetic resonance imaging; NIA-AA - National Institute on Ageing and Alzheimer's Association; NINCDS - National Institute of Neurological and Communicative Disorders and Stroke; PEN2 - presenilin enhancer 2; PET - positron emission tomography; PiB - Pittsburgh Compound B; PiB-SUVR - PIB standardized uptake value ratio; PMCA - Protein Misfolding Cycling Amplification; PrP - Prion Protein; P-tau - hyperphosphorylated tau protein; RMP - reference measurement procedure; RT-QuIC - real-time quaking-induced conversion; SiMoA - single-molecule array; ThT - thioflavin T; TSEs - Transmissible Spongiform Encephslopathies; T-tau - total tau protein.
References: Cold Spring Harb Perspect Med. 2012 Jul;2(7):a006247. (PMID: 22762014)
Annu Rev Neurosci. 2003;26:267-98. (PMID: 12704221)
Neurobiol Aging. 2004 Mar;25(3):273-81. (PMID: 15123331)
Arch Neurol. 2012 Dec;69(12):1591-7. (PMID: 23229043)
J Neurol Sci. 1998 Jun 30;158(2):134-40. (PMID: 9702683)
Alzheimers Res Ther. 2020 Mar 17;12(1):26. (PMID: 32183883)
Alzheimers Res Ther. 2019 Apr 22;11(1):34. (PMID: 31010420)
EMBO Mol Med. 2017 Sep;9(9):1212-1223. (PMID: 28743782)
Neurology. 2019 Oct 22;93(17):e1647-e1659. (PMID: 31371569)
J Prev Alzheimers Dis. 2019;6(3):150. (PMID: 31062821)
Alzheimers Dement. 2018 Apr;14(4):535-562. (PMID: 29653606)
Alzheimers Dement. 2020 Mar 10;:. (PMID: 32157811)
J Exp Med. 2020 Nov 2;217(11):. (PMID: 32725127)
Annu Rev Cell Biol. 1994;10:373-403. (PMID: 7888181)
Biochemistry. 2019 Jul 9;58(27):2953-2966. (PMID: 31198028)
Lancet Neurol. 2016 Jun;15(7):673-684. (PMID: 27068280)
J Alzheimers Dis. 2013;34(2):457-68. (PMID: 23234879)
Neurosci Lett. 2014 Jun 24;573:7-12. (PMID: 24796810)
Proc Natl Acad Sci U S A. 2009 Mar 10;106(10):4012-7. (PMID: 19228947)
Alzheimers Dement (N Y). 2020 Jul 16;6(1):e12050. (PMID: 32695874)
Neurobiol Aging. 1998 Mar-Apr;19(2):109-16. (PMID: 9558143)
Front Genet. 2019 Mar 01;10:153. (PMID: 30881384)
Proteomics. 2006 Dec;6(23):6326-53. (PMID: 17083142)
Nat Protoc. 2006;1(3):1591-5. (PMID: 17406451)
Nature. 1992 Sep 24;359(6393):325-7. (PMID: 1406936)
Alzheimers Dement. 2011 May;7(3):270-9. (PMID: 21514249)
Ann Neurol. 2006 Mar;59(3):512-9. (PMID: 16372280)
Alzheimers Res Ther. 2017 Dec 15;9(1):98. (PMID: 29246249)
Nature. 2001 Jun 14;411(6839):810-3. (PMID: 11459061)
Alzheimers Dement. 2011 May;7(3):257-62. (PMID: 21514247)
J Alzheimers Dis. 2020;75(2):493-499. (PMID: 32310175)
Neurol Ther. 2019 Dec;8(Suppl 2):113-127. (PMID: 31833028)
Arch Neurol. 2009 Feb;66(2):190-9. (PMID: 19204155)
JAMA Neurol. 2014 Apr;71(4):476-83. (PMID: 24566866)
Prion. 2018;12(5-6):261-265. (PMID: 30220236)
Nat Methods. 2007 Aug;4(8):645-50. (PMID: 17643109)
N Engl J Med. 2014 Aug 7;371(6):530-9. (PMID: 25099577)
PLoS One. 2011;6(12):e28263. (PMID: 22194817)
Sci Rep. 2016 May 31;6:26801. (PMID: 27241045)
Nat Rev Mol Cell Biol. 2007 Feb;8(2):101-12. (PMID: 17245412)
Biomolecules. 2020 Mar 19;10(3):. (PMID: 32204429)
Biology (Basel). 2020 Nov 27;9(12):. (PMID: 33260956)
Proc Natl Acad Sci U S A. 1985 Jun;82(12):4245-9. (PMID: 3159021)
Lancet. 2011 Feb 5;377(9764):487-93. (PMID: 21295339)
J Alzheimers Dis. 2016 Oct 4;54(3):1193-1205. (PMID: 27567806)
Neurosci Lett. 2001 Jan 19;297(3):187-90. (PMID: 11137759)
Neurol Genet. 2020 Oct 6;6(5):e512. (PMID: 33225065)
Expert Rev Mol Diagn. 2019 Jul;19(7):613-621. (PMID: 31177871)
Nature. 1999 Jun 24;399(6738 Suppl):A23-31. (PMID: 10392577)
Pract Neurol. 2019 Feb;19(1):49-55. (PMID: 30282760)
N Engl J Med. 2014 Aug 7;371(6):519-29. (PMID: 25099576)
Proc Natl Acad Sci U S A. 1986 Jul;83(13):4913-7. (PMID: 3088567)
Brain. 2016 Apr;139(Pt 4):1226-36. (PMID: 26936941)
Am J Pathol. 1995 Aug;147(2):503-15. (PMID: 7639340)
Nat Med. 2011 Feb;17(2):175-8. (PMID: 21278748)
Neuropathol Appl Neurobiol. 1990 Apr;16(2):111-21. (PMID: 2345598)
Ann Clin Transl Neurol. 2016 Aug 28;3(10):812-818. (PMID: 27752516)
Neurology. 1984 Jul;34(7):939-44. (PMID: 6610841)
Forum Health Econ Policy. 2014 Nov;18(1):25-39. (PMID: 27134606)
Nature. 2018 Feb 8;554(7691):249-254. (PMID: 29420472)
Nat Biotechnol. 2010 Jun;28(6):595-9. (PMID: 20495550)
Alzheimers Dement. 2018 Nov;14(11):1460-1469. (PMID: 29501462)
J Intern Med. 2018 Dec;284(6):643-663. (PMID: 30051512)
Neurology. 2020 Dec 8;95(23):e3104-e3116. (PMID: 32873693)
Cell Rep. 2014 Apr 10;7(1):261-8. (PMID: 24656814)
Nat Rev Drug Discov. 2011 Aug 19;10(9):698-712. (PMID: 21852788)
Alzheimers Res Ther. 2017 Oct 17;9(1):86. (PMID: 29041968)
Alzheimers Dement. 2011 May;7(3):263-9. (PMID: 21514250)
Nat Med. 2020 Mar;26(3):398-407. (PMID: 32161412)
Alzheimers Dement. 2019 Jul;15(7):888-898. (PMID: 31164314)
Front Aging Neurosci. 2019 May 21;11:121. (PMID: 31178717)
J Geriatr Psychiatry Neurol. 2010 Dec;23(4):213-27. (PMID: 21045163)
Alzheimers Dement. 2011 May;7(3):280-92. (PMID: 21514248)
Neurology. 2003 Feb 25;60(4):652-6. (PMID: 12601108)
Nat Methods. 2008 Mar;5(3):211-2. (PMID: 18309304)
J Mol Biol. 2009 Jan 30;385(4):1052-63. (PMID: 19038267)
Ann Neurol. 1995 Oct;38(4):643-8. (PMID: 7574461)
Ann Neurol. 2004 Mar;55(3):306-19. (PMID: 14991808)
فهرسة مساهمة: Keywords: Alzheimer’s disease; Aβ oligomers; amyloid beta; blood; early diagnostics
المشرفين على المادة: 0 (Amyloid beta-Peptides)
0 (Amyloidogenic Proteins)
0 (Biomarkers)
0 (tau Proteins)
EC 3.4.- (Amyloid Precursor Protein Secretases)
EC 3.4.23.- (Aspartic Acid Endopeptidases)
تواريخ الأحداث: Date Created: 20210429 Date Completed: 20211210 Latest Revision: 20240402
رمز التحديث: 20240402
مُعرف محوري في PubMed: PMC8096329
DOI: 10.1080/19336896.2021.1917289
PMID: 33910450
قاعدة البيانات: MEDLINE
الوصف
تدمد:1933-690X
DOI:10.1080/19336896.2021.1917289